NewGenIvf Group Limited
NIVF
$1.81
$0.0623.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.53% | 9.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.53% | 9.63% | |||
| Cost of Revenue | -10.86% | -19.53% | |||
| Gross Profit | -16.91% | 103.07% | |||
| SG&A Expenses | 276.49% | -6.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 88.02% | -15.51% | |||
| Operating Income | -603.51% | 250.42% | |||
| Income Before Tax | -1,691.09% | 84.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -84.82% | 84.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -598.10% | 338.64% | |||
| Net Income | -443.72% | 89.96% | |||
| EBIT | -603.51% | 250.42% | |||
| EBITDA | -588.30% | 262.18% | |||
| EPS Basic | -90.66% | 89.99% | |||
| Normalized Basic EPS | -1,514.61% | 93.25% | |||
| EPS Diluted | -90.66% | 89.99% | |||
| Normalized Diluted EPS | -1,514.61% | 93.25% | |||
| Average Basic Shares Outstanding | 187.13% | 0.00% | |||
| Average Diluted Shares Outstanding | 187.13% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||